Search

Your search keyword '"Ongaro E"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Ongaro E" Remove constraint Author: "Ongaro E"
225 results on '"Ongaro E"'

Search Results

2. Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA)

3. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

7. PO-1112: Total neoadjuvant therapy in high risk rectal cancer: a feasibility pilot study

8. 416P A novel prognostic tool based on lymphocyte ratios in patients with stage III colon cancer

9. A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

10. EGPA and the study of EU Public Administration

11. P-246 Taxane cross-resistance: An exploratory analysis of second-line chemotherapy for metastatic gastric cancer

12. P-266 LDH levels as predictors of efficacy in second-line treatment for metastatic gastric cancer: The LINE study

13. Risk and Blame in the Public Sector

14. Introduction

15. Europeanization of Policies and Administration

16. Collaborative Governance and the Third Sector: Something Old, Something New

17. Conclusions

19. Policy Evaluation in Europe

20. Public Administration and Public Management Research in Europe: Traditions and Trends

21. PIK3CA mutation in metastatic colorectal cancer (mCRC): Association with clinico-pathological features and outcome

22. Drug holidays and overall survival in patients treated for metastatic colorectal cancer

23. The SAFFO study: Sex-related prognostic role and cut-oFf deFinition of monocyte-to-lymphocyte ratio (MLR) in metastatic colOrectal cancer

24. SUN-PO094: The Role of Nutritional Interventions in Surgically Treated Pancreatic Cancer Patients: Comparative Efficacy in a Network Meta-Analysis (NMA)

25. The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA)

26. Languages and public administration in Europe

27. Public Sector Negotiations

28. EGPA and the study of EU Public Administration

29. Influence of the EU (and the IMF) on domestic cutback management: a nine-countries comparative analysis

31. The Contested Autonomy of Policy Advisory Bodies: The Trade-off Between Autonomy and Control of Policy Advisory Bodies in the Netherlands, the United Kingdom, and Sweden

32. E-Government and E-Governance: Bits & Bytes for Public Administration

33. Coordination in Europe

34. The Case of Case Study Research in Europe: Practice and Potential

35. HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research

36. Monocyte-to-lymphocye ratio (MLR) and LDH level in metastatic colorectal cancer (mCRC) patients (pts)

37. The SENECA study: Prognostic role of serum biomarkers in elderly metastatic colorectal cancer patients

38. Determinants of oncologist’s choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer

39. The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer

40. Molecular characterization of immune microenvironment in colorectal cancers with microsatellite instability by digital RNA counting

41. Clinical and molecular determinants of extrahepatic disease progression (ePD) in initially unresectable, liver-limited metastatic colorectal cancer (mCRC)

42. Policy evaluation in Europe

43. Factors and Determinants of the Quality of Public Administration in the CEE-Region

44. Risk and Blame in the Public Sector

45. Public Sector Negotiations

46. Conclusions

48. Public Administration and Public Management Research in Europe: Traditions and Trends

49. Europeanization of Policies and Administration

50. Languages and Public Administration in Europe

Catalog

Books, media, physical & digital resources